Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Diabetes 2015
See also Supplemental Figure 4
In the T2D mice model, liraglutide showed an effect of alleviating steatosis (Zhang et al., 2021
Explore GLPro GLPatch supply options and current pricing here
To date, these GLP-1 drugs have been approved to treat three adult populations: individuals with type 2 diabetes, individuals with a body mass index (BMI) of 30 or greater (obesity), and individuals with a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain (angina)
Study results like these remind us whats possible when innovation, evidence, and patient empowerment come together
US$ 25.36
US$ 26.44
US$ 25.02
US$ 26.47
